Latest Equity Raises News

Page 53 of 75
Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.
Ada Torres
Ada Torres
30 July 2025
Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.
Maxwell Dee
Maxwell Dee
30 July 2025
Syrah Resources has launched a fully underwritten A$70 million equity raising to support its Balama graphite operations and Vidalia Active Anode Material facility, alongside securing a two-year forbearance on its US Department of Energy loan. The company advances commercial qualification of Vidalia AAM amid strong demand and US tariff support.
Maxwell Dee
Maxwell Dee
30 July 2025
Syrah Resources has launched a A$70 million equity raising and secured a two-year forbearance on its US Department of Energy loan, bolstering its cash position and operational flexibility amid ongoing challenges.
Maxwell Dee
Maxwell Dee
30 July 2025
Transurban Group reveals modest participation in its latest Distribution Reinvestment Plan, with new securities priced at $13.4692 ahead of the August payment date.
Nora Hopper
Nora Hopper
30 July 2025
Arizona Lithium has secured regulatory approval for Phase 1 production at its Prairie Lithium Project in Saskatchewan and raised $4.25 million through an oversubscribed share purchase plan, marking key milestones toward commercial lithium extraction.
Maxwell Dee
Maxwell Dee
30 July 2025
Legacy Minerals reports a robust Stage 1 Scoping Study for its Drake Project, confirming strong economics and production potential, while inaugural drilling at the Thomson Project and a $7.75 million capital raise set the stage for accelerated exploration.
Maxwell Dee
Maxwell Dee
30 July 2025
Terra Metals has raised $4 million from strategic investors to fund further exploration at its Dante Project, where recent drilling confirms high-grade mineralisation and supports a forthcoming maiden resource estimate.
Maxwell Dee
Maxwell Dee
30 July 2025
Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.
Ada Torres
Ada Torres
30 July 2025
Vulcan Energy Resources reported significant cash outflows in the June 2025 quarter driven by exploration and development, yet maintains a robust liquidity position with nearly €49 million in cash and a €10 million credit facility.
Maxwell Dee
Maxwell Dee
30 July 2025
Linius Technologies reports a 17.7% rise in quarterly billings, secures a paid proof of concept with a major European football league, and strengthens its board with two new appointments while raising $2.35 million to fuel its SaaS video platform commercialization.
Sophie Babbage
Sophie Babbage
29 July 2025
Riedel Resources Limited has progressed its Kingman Project in Arizona, securing $1.4 million in fresh capital to fund drilling and development activities at the high-grade Tintic deposit. The company also strengthened its board with the appointment of an experienced independent director.
Maxwell Dee
Maxwell Dee
29 July 2025